Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes,Cancer Cell

当前位置： X-MOL 学术 › Cancer Cell › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
Cancer Cell ( IF 50.3 ) Pub Date : 2024-04-04 , DOI: 10.1016/j.ccell.2024.03.002
Renée Maria Saliby , Chris Labaki , Tejas R. Jammihal , Wanling Xie , Maxine Sun , Valisha Shah , Eddy Saad , M. Harry Kane , Soki Kashima , Katherine Sadak , Talal El Zarif , Deepak Poduval , Robert J. Motzer , Thomas Powles , Brian I. Rini , Laurence Albiges , Sumanta K. Pal , Bradley A. McGregor , Rana R. McKay , Sabina Signoretti , Eliezer M. Van Allen , Sachet A. Shukla , Toni K. Choueiri , David A. Braun

Abstract not available

中文翻译：